US Patent 11446387 Compositions and methods of treating muscle dystrophy
Patent 11446387 was granted and assigned to Avidity Biosciences on September, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 26, 2021
0
Date of Patent
September 20, 2022
0
Patent Applicant
Patent Application Number
17214525
0
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11446387 Compositions and methods of treating muscle dystrophy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.